The FDA officially announced semaglutide on shortage in March 2022, followed by tirzepatide and dulaglutide in December 2022, and liraglutide in July 2023.(8) Even today, two years later, the supply of these medications remains sparse
These systems will enable rapid response to emerging infectious threats by streamlining the design of antigen constructs, delivery systems, and adjuvant combinations within days rather than months [281]
Oral therapies and ultra long acting injectables are two distinct strategies to improve patient and healthcare system outcomes
Consequently, the development of small molecule ghrelin receptor agonists with extended receptor activity emerges as a promising therapeutic approach for addressing gastrointestinal motility disorders
This method ensures the vitamin enters the bloodstream quickly, bypassing any digestive issues that might hinder absorption
To achieve high voltages in practice, multiple cells must be connected in series to create the ideal high-voltage operating platform
